Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition.

Not Applicable

Recruiting

• Conditions: schizophrenia; social cognition; schizoaffective disorder; Mental Health - Schizophrenia

• Registration Number: ACTRN12621001649808
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-01
• Last Update Posted: 13 December 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Participants with a diagnosis of schizophrenia or schizoaffective disorder:

-Adults between 18 and 55 years of age.
-Diagnosis of schizophrenia or schizoaffective disorder as confirmed by the MINI 7.0.2.
-Ability to provide informed consent and show understanding of participation by relaying key information to researcher.

Healthy Volunteers:
-Adults aged 18-55 years
-No history of mental illness confirmed with MINI
-No unstable medical conditions
-No contraindications to receiving tACS (mentioned in exclusion criteria)

Exclusion Criteria

-Commencement or significant dosage alteration of other psychotropic medications (i.e., anti-depressants, anti-psychotics) during the four weeks prior to an experimental session.
-Currently taking any medication shown to interfere with the effects of tACS; namely benzodiazepines
-A current substance use or alcohol use disorder
-Any history of significant head injury or traumatic brain injury, as defined by a loss of consciousness greater than 30 minutes or requiring a hospital admission.
-Unstable medical or neurological illness.
-Pregnancy or breastfeeding.
-An uncorrected hearing or visual impairment (including difficulty with colour perception).
-Significant difficulties with understanding or communicating in English.

Study & Design

• Study Type: Interventional
• Study Design: Not specified